Aspirin and immune system

International Immunopharmacology

Volumn 12, Issue 1, 2012, Pages 10-20

  Hussain, Muzammal ^a   Javeed, Aqeel ^a   Ashraf, Muhammad ^a   Zhao, Yong ^b   Mukhtar, Muhammad Mahmood ^c   Rehman, Muti Ur ^a  

^a UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES   (Pakistan)

^b INSTITUTE OF ZOOLOGY   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aspirin; Autoimmunity; Immune tolerance; Immunosuppressant; NO aspirin; Tolerogenic dendritic cells

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; CELECOXIB; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 8; PROSTANOID; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFICACY; EFFECTOR CELL; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; IMMUNOPOTENTIATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; AUTOIMMUNE DISEASES; DENDRITIC CELLS; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; INFLAMMATION; LEUKOCYTES; MACROPHAGES;

EID: 84856090985     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.11.021     Document Type: Review

References (163)

1. B.A. Leaberry Aspirin for the prevention of cardiovascular disease: systematic review J Nurs Care Qual 25 2010 17 21
2. S. Fiorucci, and P. Del Soldato NO-aspirin: mechanism of action and gastrointestinal safety Dig Liver Dis 35 Suppl. 2 2003 S9 S19
3. S. Fiorucci, L. Santucci, P. Gresele, R.M. Faccino, P. Del Soldato, and A. Morelli Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study Gastroenterology 124 2003 600 607 (Pubitemid 36268478)
4. J.L. Wallace Nitric oxide, aspirin-triggered lipoxins and NO-aspirin in gastric protection Inflamm Allergy Drug Targets 5 2006 133 137 (Pubitemid 43796675)
5. R.M. Botting Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology Pharmacol Rep 62 2010 518 525
6. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat New Biol 231 1971 232 235
7. N. Chiang, and C.N. Serhan New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications Compr Ther 32 2006 150 157 (Pubitemid 46706466)
8. D.W. Gilroy The role of aspirin-triggered lipoxins in the mechanism of action of aspirin Prostaglandins Leukot Essent Fatty Acids 73 2005 203 210 (Pubitemid 41253477)
9. D. Taubert, R. Berkels, N. Grosser, H. Schroder, D. Grundemann, and E. Schomig Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action Br J Pharmacol 143 2004 159 165 (Pubitemid 39280035)
10. B.N. Cronstein, M.C. Montesinos, and G. Weissmann Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB Proc Natl Acad Sci U S A 96 1999 6377 6381 (Pubitemid 29256673)
11. B.N. Cronstein, M. Van de Stouwe, L. Druska, R.I. Levin, and G. Weissmann Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: adenosine dependent and independent mechanisms Inflammation 18 1994 323 335 (Pubitemid 24232684)
12. E. Kopp, and S. Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science (New York, NY) 265 1994 956 959
13. C.C. Goodnow, J. Sprent, B. Fazekas de St Groth, and C.G. Vinuesa Cellular and genetic mechanisms of self tolerance and autoimmunity Nature 435 2005 590 597 (Pubitemid 40825498)
14. L. Van Parijs, and A.K. Abbas Homeostasis and self-tolerance in the immune system: turning lymphocytes off Science (New York, NY) 280 1998 243 248 (Pubitemid 28178061)
15. G.H. Ring, and F.G. Lakkis Breakdown of self-tolerance and the pathogenesis of autoimmunity Semin Nephrol 19 1999 25 33 (Pubitemid 29048843)
16. B.E. Barton Innate immunity: the bridge between adaptive immunity and inflammation, December 17, 1998, New York Academy of Sciences, New York, NY, USA Inflamm Res 48 1999 232 235 (Pubitemid 29257612)
17. C.A. Feghali, and T.M. Wright Cytokines in acute and chronic inflammation Front Biosci 2 1997 d12 d26
18. B. Rocca, and G.A. FitzGerald Cyclooxygenases and prostaglandins: shaping up the immune response Int Immunopharmacol 2 2002 603 630 (Pubitemid 34246363)
19. S.L. Tilley, T.M. Coffman, and B.H. Koller Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes J Clin Invest 108 2001 15 23 (Pubitemid 32634916)
20. T. Bryn, S. Yaqub, M. Mahic, K. Henjum, E.M. Aandahl, and K. Tasken LPS-activated monocytes suppress T-cell immune responses and induce FOXP3 + T cells through a COX-2-PGE2-dependent mechanism Int Immunol 20 2008 235 245 (Pubitemid 351234391)
21. T.J. Hall, and J. Brostoff Inhibition of human natural killer cell activity by prostaglandin D2 Immunol Lett 7 1983 141 144 (Pubitemid 14150893)
22. H. Hammad, H.J. de Heer, T. Soullie, H.C. Hoogsteden, F. Trottein, and B.N. Lambrecht Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1 J Immunol 171 2003 3936 3940 (Pubitemid 37238665)
23. S.G. Harris, R.S. Smith, and R.P. Phipps 15-Deoxy-delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway J Immunol 168 2002 1372 1379 (Pubitemid 34094508)
24. K. Kabashima, T. Murata, H. Tanaka, T. Matsuoka, D. Sakata, and N. Yoshida Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity Nat Immunol 4 2003 694 701 (Pubitemid 36874447)
25. I.Y. Lee, E.M. Ko, S.H. Kim, D.I. Jeoung, and J. Choe Human follicular dendritic cells express prostacyclin synthase: a novel mechanism to control T cell numbers in the germinal center J Immunol 175 2005 1658 1664 (Pubitemid 41023069)
26. Y. Li, P.Y. Lee, and W.H. Reeves Monocyte and macrophage abnormalities in systemic lupus erythematosus Arch Immunol Ther Exp (Warsz) 58 2010 355 364
27. T. Matsuo, T. Matsumura, M. Sakai, T. Senokuchi, M. Yano, and S. Kiritoshi 15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB Biochem Biophys Res Commun 314 2004 817 823 (Pubitemid 38112872)
28. M.A. Monroy, K.K. Opperman, M. Pucciarelli, S. Yerrum, D.A. Berg, and J.M. Daly THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model Shock 28 2007 186 191 (Pubitemid 47220830)
29. M.T. Rubio, T.K. Means, R. Chakraverty, J. Shaffer, Y. Fudaba, and M. Chittenden Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs Int Immunol 17 2005 1561 1572 (Pubitemid 41754679)
30. G. Theiner, A. Gessner, and M.B. Lutz The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo Immunobiology 211 2006 463 472
31. D.W. Thomas, P.N. Rocha, C. Nataraj, L.A. Robinson, R.F. Spurney, and B.H. Koller Proinflammatory actions of thromboxane receptors to enhance cellular immune responses J Immunol 171 2003 6389 6395 (Pubitemid 37532066)
32. S. Wrenger, J. Faust, C. Mrestani-Klaus, A. Fengler, A. Stockel-Maschek, and S. Lorey Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor J Biol Chem 275 2000 22180 22186 (Pubitemid 30621799)
33. S.G. Harris, J. Padilla, L. Koumas, D. Ray, and R.P. Phipps Prostaglandins as modulators of immunity Trends Immunol 23 2002 144 150 (Pubitemid 34178297)
34. A. Cloutier, T. Ear, E. Blais-Charron, C.M. Dubois, and P.P. McDonald Differential involvement of NF-kappaB and MAP kinase pathways in the generation of inflammatory cytokines by human neutrophils J Leukoc Biol 81 2007 567 577 (Pubitemid 46198409)
35. Z.G. Luan, P. Nala, Z.D. Zhang, and X.C. Ma Therapeutic effects of low molecular weight heparin and aspirin on acute lung injury in rat Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18 2006 456 458 (Pubitemid 44256064)
36. M.H. Pillinger, C. Capodici, P. Rosenthal, N. Kheterpal, S. Hanft, and M.R. Philips Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion Proc Natl Acad Sci U S A 95 1998 14540 14545 (Pubitemid 28549403)
37. G. Weissmann, M.C. Montesinos, M. Pillinger, and B.N. Cronstein Non-prostaglandin effects of aspirin III and salicylate: inhibition of integrin-dependent human neutrophil aggregation and inflammation in COX 2- and NF kappa B (P105)-knockout mice Adv Exp Med Biol 507 2002 571 577 (Pubitemid 37330237)
38. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution Prostaglandins Other Lipid Mediat 68-69 2002 433 455 (Pubitemid 35247413)
39. C.B. Clish, J.A. O'Brien, K. Gronert, G.L. Stahl, N.A. Petasis, and C.N. Serhan Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo Proc Natl Acad Sci U S A 96 1999 8247 8252 (Pubitemid 29328440)
40. J.G. Filep, T. Khreiss, and L. Jozsef Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction Prostaglandins Leukot Essent Fatty Acids 73 2005 257 262 (Pubitemid 41253484)
41. I.M. Fierro, S.P. Colgan, G. Bernasconi, N.A. Petasis, C.B. Clish, and M. Arita Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells J Immunol 170 2003 2688 2694 (Pubitemid 36245662)
42. C.N. Serhan, I.M. Fierro, N. Chiang, and M. Pouliot Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4 J Immunol 166 2001 3650 3654 (Pubitemid 32224884)
43. N. Chiang, M. Arita, and C.N. Serhan Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX Prostaglandins Leukot Essent Fatty Acids 73 2005 163 177 (Pubitemid 41253473)
44. N. Chiang, I.M. Fierro, K. Gronert, and C.N. Serhan Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation J Exp Med 191 2000 1197 1208
45. M.J. Paul-Clark, T. Van Cao, N. Moradi-Bidhendi, D. Cooper, and D.W. Gilroy 15-Epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation J Exp Med 200 2004 69 78 (Pubitemid 38924729)
46. J. Goh, A.W. Baird, C. O'Keane, R.W. Watson, D. Cottell, and G. Bernasconi Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo J Immunol 167 2001 2772 2780 (Pubitemid 32768909)
47. T. Ohira, G. Bannenberg, M. Arita, M. Takahashi, Q. Ge, and T.E. Van Dyke A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils J Immunol 173 2004 2091 2098 (Pubitemid 38971647)
48. Y.P. Sun, S.F. Oh, J. Uddin, R. Yang, K. Gotlinger, and E. Campbell Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation J Biol Chem 282 2007 9323 9334 (Pubitemid 47104612)
49. S. Fiorucci, E. Distrutti, A. Mencarelli, G. Rizzo, A.R. Lorenzo, and M. Baldoni Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence J Pharmacol Exp Ther 309 2004 1174 1182 (Pubitemid 38669707)
50. S. Negrotto, E. Malaver, M.E. Alvarez, N. Pacienza, L.P. D'Atri, and R.G. Pozner Aspirin and salicylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli J Pharmacol Exp Ther 319 2006 972 979
51. D. El Kebir, L. Jozsef, W. Pan, L. Wang, N.A. Petasis, and C.N. Serhan 15-Epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury Am J Respir Crit Care Med 180 2009 311 319
52. D. El Kebir, L. Jozsef, T. Khreiss, W. Pan, N.A. Petasis, and C.N. Serhan Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation J Immunol 179 2007 616 622 (Pubitemid 46986579)
53. M.T. Silva When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system J Leukoc Biol 87 2010 93 106
54. H.L. Twigg III Macrophages in innate and acquired immunity Semin Respir Crit Care Med 25 2004 21 31
55. N. Fujiwara, and K. Kobayashi Macrophages in inflammation Curr Drug Targets Inflamm Allergy 4 2005 281 286 (Pubitemid 40873112)
56. C. Weber, W. Erl, A. Pietsch, and P.C. Weber Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells Circulation 91 1995 1914 1917
57. G.L. Fricchione, T.V. Bilfinger, and G.B. Stefano Aspirin inhibits granulocyte and monocyte adherence to saphenous vein endothelia in a process not mediated by nitric oxide Int J Cardiol 64 Suppl. 1 1998 S29 S33
58. T. Morris, M. Stables, A. Hobbs, P. de Souza, P. Colville-Nash, and T. Warner Effects of low-dose aspirin on acute inflammatory responses in humans J Immunol 183 2009 2089 2096
59. I.E. Hoefer, S. Grundmann, S. Schirmer, N. van Royen, B. Meder, and C. Bode Aspirin, but not clopidogrel, reduces collateral conductance in a rabbit model of femoral artery occlusion J Am Coll Cardiol 46 2005 994 1001 (Pubitemid 41316505)
60. R. Voisard, R. Fischer, M. Osswald, S. Voglic, R. Baur, and M. Susa Aspirin (5 mmol/L) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model Circulation 103 2001 1688 1694 (Pubitemid 32246618)
61. T.J. Fischer, S.E. Gard, G.S. Rachelefsky, R.B. Klein, T.C. Borut, and E.R. Stiehm Monocyte chemotaxis under agarose: defects in atopic disease, aspirin therapy, and mucocutaneous candidiasis Pediatr Res 14 1980 242 246 (Pubitemid 10133521)
62. R.E. Shackelford, P.B. Alford, Y. Xue, S.F. Thai, D.O. Adams, and S. Pizzo Aspirin inhibits tumor necrosis factoralpha gene expression in murine tissue macrophages Mol Pharmacol 52 1997 421 429 (Pubitemid 27412967)
63. J.Y. Cho Immunomodulatory effect of nonsteroidal anti-inflammatory drugs (NSAIDs) at the clinically available doses Arch Pharm Res 30 2007 64 74
64. D. Kepka-Lenhart, L.C. Chen, and S.M. Morris Jr. Novel actions of aspirin and sodium salicylate: discordant effects on nitric oxide synthesis and induction of nitric oxide synthase mRNA in a murine macrophage cell line J Leukoc Biol 59 1996 840 846 (Pubitemid 26238480)
65. E.E. Aeberhard, S.A. Henderson, N.S. Arabolos, J.M. Griscavage, F.E. Castro, and C.T. Barrett Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene Biochem Biophys Res Commun 208 1995 1053 1059
66. S. Fiorucci, L. Santucci, E. Antonelli, E. Distrutti, G. Del Sero, and O. Morelli NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines Gastroenterology 118 2000 404 421 (Pubitemid 30067514)
67. S. Fiorucci, A. Mencarelli, A. Meneguzzi, A. Lechi, A. Morelli, and P. del Soldato NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide Circulation 106 2002 3120 3125 (Pubitemid 35440298)
68. S. Fiorucci, A. Mencarelli, A. Meneguzzi, A. Lechi, B. Renga, and P. del Soldato Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans J Am Coll Cardiol 44 2004 635 641 (Pubitemid 39078192)
69. P. Minuz, M. Degan, S. Gaino, A. Meneguzzi, V. Zuliani, and C.L. Santonastaso NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes Br J Pharmacol 134 2001 905 911 (Pubitemid 33016163)
70. E. Ricciotti, M. Dovizio, L. Di Francesco, P. Anzellotti, T. Salvatore, and A. Di Francesco NCX 4040, a nitric oxide-donating aspirin, exerts anti-inflammatory effects through inhibition of I kappa B-alpha degradation in human monocytes J Immunol 184 2010 2140 2147
71. C.M. Turnbull, P. Marcarino, T.A. Sheldrake, L. Lazzarato, C. Cena, and R. Fruttero A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages J Inflamm 5 2008 12
72. A. Javeed, Y. Hou, K. Duan, B. Zhang, H. Shen, and Y. Cao Aspirin significantly decreases the nonopsonic phagocytosis and immunogenicity of macrophages in mice Inflamm Res 60 2010 389 398
73. K. Schroecksnadel, C. Winkler, B. Wirleitner, H. Schennach, and D. Fuchs Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro Clin Exp Immunol 140 2005 41 45 (Pubitemid 40461071)
74. B. Bufan, S. Mojsilovic, D. Vucicevic, D. Vucevic, S. Vasilijic, and B. Balint Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro Int Immunopharmacol 9 2009 910 917
75. N.M. Graham, C.J. Burrell, R.M. Douglas, P. Debelle, and L. Davies Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers J Infect Dis 162 1990 1277 1282
76. M.S. Molinuevo, S.B. Etcheverry, and A.M. Cortizo Macrophage activation by a vanadyl-aspirin complex is dependent on L-type calcium channel and the generation of nitric oxide Toxicology 210 2005 205 212 (Pubitemid 40517164)
77. A.S. Yong, G.J. Pennings, M. Chang, A. Hamzah, T. Chung, and M. Qi Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel Blood 117 2011 11 20
78. L.T. Osnes, K.B. Haug, G.B. Joo, A.B. Westvik, R. Ovstebo, and P. Kierulf Aspirin potentiates LPS-induced fibrin formation (FPA) and TNF-alpha-synthesis in whole blood Thromb Haemost 83 2000 868 873 (Pubitemid 30411685)
79. B. Osterud, J.O. Olsen, and L. Wilsgard Increased lipopolysaccharide- induced tissue factor activity and tumour necrosis factor production in monocytes after intake of aspirin: possible role of prostaglandin E2 Blood Coagul Fibrinolysis 3 1992 309 313
80. M.R. Peltier, D.S. Faux, S.D. Hamblin, C. Cooper, R.M. Silver, and M.S. Esplin Effect of aspirin treatment on TNFalpha production by women with a history of preterm birth J Reprod Immunol 80 2009 109 114
81. R.L. Simoes, and I.M. Fierro Involvement of the Rho-kinase/myosin light chain kinase pathway on human monocyte chemotaxis induced by ATL-1, an aspirin-triggered lipoxin A4 synthetic analog J Immunol 175 2005 1843 1850 (Pubitemid 41023090)
82. S. Mitchell, G. Thomas, K. Harvey, D. Cottell, K. Reville, and G. Berlasconi Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo J Am Soc Nephrol 13 2002 2497 2507
83. K. Palucka, and J. Banchereau Dendritic cells: a link between innate and adaptive immunity J Clin Immunol 19 1999 12 25 (Pubitemid 29113329)
84. N. Novak, and T. Bieber 2. Dendritic cells as regulators of immunity and tolerance J Allergy Clin Immunol 121 2008 S370 S374 quiz S413
85. H.J. Kim, Y.H. Lee, S.A. Im, K. Kim, and C.K. Lee Cyclooxygenase inhibitors, aspirin and ibuprofen, inhibit MHC-restricted antigen presentation in dendritic cells Immune Netw 10 2010 92 98
86. R. Matasic, A.B. Dietz, and S. Vuk-Pavlovic Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin Immunology 101 2000 53 60
87. H. Hackstein, A.E. Morelli, A.T. Larregina, R.W. Ganster, G.D. Papworth, and A.J. Logar Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells J Immunol 166 2001 7053 7062 (Pubitemid 32525574)
88. L.J. Ho, D.M. Chang, H.Y. Shiau, C.H. Chen, T.Y. Hsieh, and Y.L. Hsu Aspirin differentially regulates endotoxin-induced IL-12 and TNF-alpha production in human dendritic cells Scand J Rheumatol 30 2001 346 352
89. M. Buckland, and G. Lombardi Aspirin and the induction of tolerance by dendritic cells Handb Exp Pharmacol 2009 197 213
90. F.S. Machado, J.E. Johndrow, L. Esper, A. Dias, A. Bafica, and C.N. Serhan Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent Nat Med 12 2006 330 334 (Pubitemid 43355082)
91. F.S. Machado, L. Esper, A. Dias, R. Madan, Y. Gu, and D. Hildeman Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6 J Exp Med 205 2008 1077 1086 (Pubitemid 351679683)
92. A. Moretta, E. Marcenaro, S. Parolini, G. Ferlazzo, and L. Moretta NK cells at the interface between innate and adaptive immunity Cell Death Differ 15 2008 226 233
93. P.H. Grohmann, F. Porzsolt, I. Quirt, R.G. Miller, and R.A. Phillips Stimulation of human NK cell activity by cultured cells. II. Ingestion of aspirin by blood donors suppresses induced NK activity Clin Exp Immunol 44 1981 611 614 (Pubitemid 11066960)
94. F. Porzsolt, and W. Wolf Modulation of natural killer activity by aspirin: I. In vitro effect of aspirin J Interferon Res 3 1983 11 17 (Pubitemid 14222315)
95. R. Gerli, P. Gresele, O. Bistoni, C. Paolucci, L. Lanfrancone, and S. Fiorucci Salicylates inhibit T cell adhesion on endothelium under nonstatic conditions: induction of L-selectin shedding by a tyrosine kinase-dependent mechanism J Immunol 166 2001 832 840 (Pubitemid 32060235)
96. R. Gerli, C. Paolucci, P. Gresele, O. Bistoni, S. Fiorucci, and C. Muscat Salicylates inhibit adhesion and transmigration of T lymphocytes by preventing integrin activation induced by contact with endothelial cells Blood 92 1998 2389 2398 (Pubitemid 28452982)
97. T. Yotsui, O. Yasuda, H. Kawamoto, M. Higuchi, Y. Chihara, and E. Umemoto Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cells FEBS Lett 581 2007 427 432 (Pubitemid 46149614)
98. A. Javeed, B. Zhang, Y. Qu, A. Zhang, C. Sun, and L. Zhang The significantly enhanced frequency of functional CD4 + CD25 + Foxp3 + T regulatory cells in therapeutic dose aspirin-treated mice Transpl Immunol 20 2009 253 260
99. T. Yamaza, Y. Miura, Y. Bi, Y. Liu, K. Akiyama, and W. Sonoyama Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents PLoS One 3 2008 e2615
100. T. Dujic, A. Causevic, and M. Malenica The effects of different concentrations of acetylsalicylic acid on proliferation and viability of lymphocytes in cell culture Bosn J Basic Med Sci 8 2008 210 213
101. L. Hu, J. Shi, and L. Wang Down-regulation of beta-catenin nuclear localization by aspirin correlates with growth inhibition of Jurkat cell line J Huazhong Univ Sci Technolog Med Sci 26 2006 731 734
102. M.Z. Zailaie Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients Saudi Med J 26 2005 1085 1091 (Pubitemid 41223109)
103. M. Iannacone, G. Sitia, I. Narvaiza, Z.M. Ruggeri, and L.G. Guidotti Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus Clin Vaccine Immunol 14 2007 1532 1535 (Pubitemid 350304051)
104. D. Iglesias-Serret, M. Pique, M. Barragan, A.M. Cosialls, A.F. Santidrian, and D.M. Gonzalez-Girones Aspirin induces apoptosis in human leukemia cells independently of NF-kappaB and MAPKs through alteration of the Mcl-1/Noxa balance Apoptosis 15 2010 219 229
105. J.Q. Liu, F.X. Chen, B. Zhu, S. Zhang, J. Zhang, and Z.Z. Tao The effect of aspirin on human's gammadeltaT cells killing digestive system tumor cell lines Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24 2008 966 968
106. A. Ariel, N. Chiang, M. Arita, N.A. Petasis, and C.N. Serhan Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells J Immunol 170 2003 6266 6272 (Pubitemid 36682612)
107. M.Z. Zailaie Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment Saudi Med J 26 2005 799 805 (Pubitemid 40903346)
108. S. Fiorucci, A. Mencarelli, E. Distrutti, M. Baldoni, P. del Soldato, and A. Morelli Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs J Immunol 173 2004 874 882 (Pubitemid 38930813)
109. A. Cianferoni, J.T. Schroeder, J. Kim, J.W. Schmidt, L.M. Lichtenstein, and S.N. Georas Selective inhibition of interleukin-4 gene expression in human T cells by aspirin Blood 97 2001 1742 1749 (Pubitemid 32217242)
110. J.M. Bailey, C.E. Low, and M.B. Pupillo Reye's syndrome and aspirin use: a possible immunological relationship Prostaglandins Leukot Med 8 1982 211 218 (Pubitemid 12119479)
111. C. Brouard, and M. Pascaud Modulation of rat and human lymphocyte function by n-6 and n-3 polyunsaturated fatty acids and acetylsalicylic acid Ann Nutr Metab 37 1993 146 159 (Pubitemid 23233797)
112. A.G. Schapowal, H.U. Simon, and M. Schmitz-Schumann Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis Acta Otorhinolaryngol Belg 49 1995 235 250
113. M.L. Taylor, G.A. Stewart, and P.J. Thompson The effect of aspirin on mononuclear cells in aspirin-sensitive asthmatics and control subjects Int Arch Allergy Immunol 100 1993 156 163 (Pubitemid 23095955)
114. E.M. Varga, M.R. Jacobson, K. Masuyama, S. Rak, S.J. Till, and Y. Darby Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis Eur Respir J 14 1999 610 615 (Pubitemid 29479727)
115. T.C. Cesario, S. Yousefi, and G. Carandang The regulation of interferon production by aspirin, other inhibitors of the cyclooxygenase pathway and agents influencing calcium channel flux Bull N Y Acad Med 65 1989 26 35 (Pubitemid 19065025)
116. A. Ducatenzeiler, and J. Menezes Human gamma interferon induction by staphylococcal protein A: effector cells, kinetics and the effect of prostaglandin, indomethacin, ibuprofen and aspirin Int J Immunopharmacol 10 1988 81 91 (Pubitemid 18038172)
117. J. Hsia, N. Sarin, J.H. Oliver, and A.L. Goldstein Aspirin and thymosin increase interleukin-2 and interferon-gamma production by human peripheral blood lymphocytes Immunopharmacology 17 1989 167 173 (Pubitemid 19151489)
118. J.E. Crout, B. Hepburn, and R.E. Ritts Jr. Suppression of lymphocyte transformation after aspirin ingestion N Engl J Med 292 1975 221 223
119. M.W. Duncan, D.A. Person, R.R. Rich, and J.T. Sharp Aspirin and delayed type hypersensitivity Arthritis Rheum 20 1977 1174 1178
120. S. Nasser, P.E. Christie, R. Pfister, A.R. Sousa, A. Walls, and M. Schmitz-Schumann Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects Thorax 51 1996 64 70 (Pubitemid 26047104)
121. G. Uhlenbruck, H. Lotzerich, J. Bernhardt, and K. Rogalla Acetylsalicylic acid has no effects on various isolated immune cells in vitro Eur J Appl Physiol Occup Physiol 66 1993 473 476 (Pubitemid 23238827)
122. S. Sakaguchi Regulatory T. cells: history and perspective Methods Mol Biol 707 2011 3 17
123. R.A. Maldonado, and U.H. von Andrian How tolerogenic dendritic cells induce regulatory T cells Adv Immunol 108 2010 111 165
124. M. Buckland, C. Jago, H. Fazekesova, A. George, R. Lechler, and G. Lombardi Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells Int Immunopharmacol 6 2006 1895 1901
125. M. Buckland, C.B. Jago, H. Fazekasova, K. Scott, P.H. Tan, and A.J. George Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells Am J Transplant 6 2006 2046 2059 (Pubitemid 44199539)
126. A. Hernandez, M. Burger, B.B. Blomberg, W.A. Ross, J.J. Gaynor, and I. Lindner Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches Hum Immunol 68 2007 715 729 (Pubitemid 47379978)
127. S. Bancos, M.P. Bernard, D.J. Topham, and R.P. Phipps Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells Cell Immunol 258 2009 18 28
128. N. Kondo, A. Takao, and T. Orii Case report: immunoglobulin A deficiency in patients with juvenile rheumatoid arthritis treated with aspirin Biotherapy 7 1993 59 62
129. K. Kushima, K. Oda, S. Sakuma, S. Furusawa, and M. Fujiwara Effect of prenatal administration of NSAIDs on the immune response in juvenile and adult rats Toxicology 232 2007 257 267 (Pubitemid 46442886)
130. B. Bellosillo, M. Pique, M. Barragan, E. Castano, N. Villamor, and D. Colomer Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells Blood 92 1998 1406 1414 (Pubitemid 28369055)
131. T. Tanaka, A. Kurose, H.D. Halicka, X. Huang, F. Traganos, and Z. Darzynkiewicz Nitrogen oxide-releasing aspirin induces histone H2AX phosphorylation, ATM activation and apoptosis preferentially in S-phase cells: involvement of reactive oxygen species Cell Cycle 5 2006 1669 1674 (Pubitemid 44285254)
132. S.F. Liu, H. Wang, Z.J. Li, X.Y. Deng, H. Xiang, and Y.G. Tao Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells Eur J Pharmacol 589 2008 8 13
133. J. Debowy, B. Obminska-Domoradzka, M. Switala, and T. Garbulinski Influence of nonsteroid anti-inflammatory drugs on lymphocyte subpopulation and on the primary humoral response in normothermic and feverish rabbits Arch Immunol Ther Exp (Warsz) 37 1989 609 615 (Pubitemid 20365336)
134. K. Phadke, J. Carroll, and S. Nanda Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats Clin Exp Immunol 47 1982 579 586 (Pubitemid 12171949)
135. A. Franch, C. Castellote, and M. Castell Effect of acetylsalicylic acid and dexamethasone on antibody production in adjuvant arthritis Rheumatol Int 14 1994 27 31 (Pubitemid 24189747)
136. R. Yamazaki, N. Kusunoki, T. Matsuzaki, S. Hashimoto, and S. Kawai Aspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cells J Pharm Pharmacol 54 2002 1675 1679 (Pubitemid 36018817)
137. L. Zhang, A.M. Bertucci, K.A. Smith, L. Xu, and S.K. Datta Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus Arthritis Rheum 56 2007 4132 4141 (Pubitemid 350262341)
138. G.K. Hansson, P. Libby, U. Schonbeck, and Z.Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291 (Pubitemid 34976993)
139. G.S. Getz Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis J Lipid Res 46 2005 1 10
140. A. Amberger, M. Hala, M. Saurwein-Teissl, B. Metzler, B. Grubeck-Loebenstein, and Q. Xu Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins Mol Med 5 1999 117 128 (Pubitemid 29230690)
141. J.F. Shaw Prolongation of rat cardiac allograft survival by treatment with prostacyclin or aspirin during acute rejection Transplantation 35 1983 526 529 (Pubitemid 13064581)
142. T. Yokoyama, O. Aramaki, T. Takayama, S. Takano, Q. Zhang, and M. Shimazu Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4 + regulatory cells J Thorac Cardiovasc Surg 130 2005 1167 1174 (Pubitemid 41427356)
143. W. Grotz, S. Siebig, M. Olschewski, C.W. Strey, and K. Peter Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation Transplantation 77 2004 1848 1853 (Pubitemid 38822207)
144. E. Torsney, U. Mayr, Y. Zou, W.D. Thompson, Y. Hu, and Q. Xu Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection Circ Res 94 2004 1466 1473 (Pubitemid 38780319)
145. W. Hansen, A.M. Westendorf, and J. Buer Regulatory T cells as targets for immunotherapy of autoimmunity and inflammation Inflamm Allergy Drug Targets 7 2008 217 223
146. N. Ohkura, M. Hamaguchi, and S. Sakaguchi FOXP3 + regulatory T cells: control of FOXP3 expression by pharmacological agents Trends Pharmacol Sci 32 2011 158 166
147. J.J. Haddad, N.E. Saade, and B. Safieh-Garabedian Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary- adrenal revolving axis J Neuroimmunol 133 2002 1 19 (Pubitemid 35346723)
148. M. Stein, and A.H. Miller Stress, the hypothalamic-pituitary-adrenal axis, and immune function Adv Exp Med Biol 335 1993 1 5 (Pubitemid 23294287)
149. H. Imura, and J. Fukata Endocrine-paracrine interaction in communication between the immune and endocrine systems. Activation of the hypothalamic- pituitary-adrenal axis in inflammation Eur J Endocrinol 130 1994 32 37 (Pubitemid 24110430)
150. R. Derijk, and F. Berkenbosch The immune-hypothalamo-pituitary-adrenal axis and autoimmunity Int J Neurosci 59 1991 91 100
151. M.S. Harbuz, G.L. Conde, O. Marti, S.L. Lightman, and D.S. Jessop The hypothalamic-pituitary-adrenal axis in autoimmunity Ann N Y Acad Sci 823 1997 214 224 (Pubitemid 27424901)
152. E.O. Johnson, M. Kostandi, and H.M. Moutsopoulos Hypothalamic-pituitary- adrenal axis function in Sjogren's syndrome: mechanisms of neuroendocrine and immune system homeostasis Ann N Y Acad Sci 1088 2006 41 51 (Pubitemid 47092039)
153. S. Poliak, F. Mor, P. Conlon, T. Wong, N. Ling, and J. Rivier Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary- adrenal axis and the immune system J Immunol 158 1997 5751 5756 (Pubitemid 127483980)
154. A.M. Puebla-Perez, X. Lozoya, and M.M. Villasenor-Garcia Effect of Ginkgo biloba extract, EGb 761, on the cellular immune response in a hypothalamic-pituitary-adrenal axis activation model in the rat Int Immunopharmacol 3 2003 75 80 (Pubitemid 36106452)
155. M.M. Villasenor-Garcia, X. Lozoya, L. Osuna-Torres, J.M. Viveros-Paredes, L. Sandoval-Ramirez, and A.M. Puebla-Perez Effect of Ginkgo biloba extract EGb 761 on the nonspecific and humoral immune responses in a hypothalamic-pituitary- adrenal axis activation model Int Immunopharmacol 4 2004 1217 1222 (Pubitemid 38900858)
156. E. Redei, W.R. Clark, and R.F. McGivern Ethanol induced alteration of immune function may involve hormones of the hypothalamic-pituitary-adrenal axis Prog Clin Biol Res 325 1990 313 320
157. A.J. Bugajski, P. Thor, R. Glod, A. Gadek-Michalska, and J. Bugajski Influence of cyclooxygenase inhibitors on the central histaminergic stimulations of hypothalamic-pituitary-adrenal axis J Physiol Pharmacol 54 2003 643 652 (Pubitemid 38029757)
158. K.M. Buller, Y. Xu, and T.A. Day Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1 beta J Neuroendocrinol 10 1998 519 528 (Pubitemid 28310598)
159. S.M. Parsadaniantz, A. Lebeau, P. Duval, B. Grimaldi, B. Terlain, and B. Kerdelhue Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat J Neuroendocrinol 12 2000 766 773 (Pubitemid 30497103)
160. G.I. Hockings, J.E. Grice, G.V. Crosbie, M.M. Walters, A.J. Jackson, and R.V. Jackson Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation J Clin Endocrinol Metab 77 1993 404 408 (Pubitemid 23230048)
161. E.J. Nye, G.I. Hockings, J.E. Grice, D.J. Torpy, M.M. Walters, and G.V. Crosbie Aspirin inhibits vasopressin-induced hypothalamic-pituitary-adrenal activity in normal humans J Clin Endocrinol Metab 82 1997 812 817 (Pubitemid 27106593)
162. J. Bugajski Role of prostaglandins in the stimulation of the hypothalamic-pituitary-adrenal axis by adrenergic and neurohormone systems J Physiol Pharmacol 47 1996 559 575 (Pubitemid 27028829)
163. B. Garcia-Bueno, J. Serrats, and P.E. Sawchenko Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary- adrenal axis activation by inflammatory stimuli J Neurosci 29 2009 12970 12981